Bringing innovative therapeutics to market requires faster, smarter clinical development strategies. As R&D investments ...
The FDA has approved Regeneron's Pasatru to reduce the formation of new abnormal bone and clinician-assessed flare-ups in ...
Novo Nordisk is testing whether lower maintenance doses of the drug can still help people lose weight in a new ...
Earlier this year, we discussed a collaborative effort between Merck and Moderna, two large biotechnology pharmaceutical ...
The U.S. FDA banned SimplyThick in baby formula after a 2012 investigation linked it to necrotizing enterocolitis, a serious ...
Can VR Nature Scenes Help Astronauts Stay Well? This is what a recent study published in Frontiers in Psychology hopes to ...
Later-life use of estrogen-only hormone therapy was associated with 39% lower odds of a clinical dementia diagnosis. | Drug ...
The goal of most anti-cancer approaches, including chemotherapy, radiation, immunotherapies, targeted therapies, and bone ...
In 2019, a phase 2 clinical trial (NCT01516216) investigated combining chemotherapy with vitamin D3 (VD3) for the treatment ...
A new publication in Nature Aging identifies a new link between sugar and cancer. The study focuses on cellular senescence, ...
Crohn’s disease (CD) develops over years before clinical diagnosis, providing a critical window to uncover early disease biology and opportunities for intervention. In this webinar, discover how ...
Two nuclear medicine leaders, Curium and Lantheus, will merge their businesses. This arrangement will place Lantheus under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results